DOCK8 gene mutation alters cell subsets, BCR signaling, and cell metabolism in B cells

作者：Heng Gu, Miaomiao Xie, Siyu Zhao, Xudong Luo, Yanmei Huang, Yang Lü, Fei Guan, Jiahui Lei, Chaohong Liu · 发表于：Cell Death and Disease · 年份：2024 · DOI：10.1038/s41419-024-07180-w · 被引用次数：10 · 研究领域：Immunodeficiency and Autoimmune Disorders、T-cell and B-cell Immunology、Immune Cell Function and Interaction

DOCK8 deficiency has been shown to affect the migration, function, and survival of immune cells in innate and adaptive immune responses. The immunological mechanisms underlying autosomal recessive (AR) hyper-IgE syndrome (AR-HIES) caused by DOCK8 mutations remain unclear, leading to a lack of specific therapeutic options. In this study, we used CRISPR/Cas9 technology to develop a mouse model with a specific DOCK8 point mutation in exon 45 (c.5846C>A), which is observed in patients with AR-HIES. We then investigated the effect of this mutation on B cell development, cell metabolism, and function in a mouse model with Dock8 gene mutation. The results demonstrated that Dock8 gene mutation inhibited splenic MZ and GC B cell development and crippled BCR signaling. In addition, it resulted in enhanced glycolysis in B cells. Mechanistically, the reduced BCR signaling was related to decreased B cell spreading, BCR clustering, and signalosomes, mediated by inhibited activation of WASP. Furthermore, the DOCK8 mutation led to increased expression of c-Myc in B cells, which plays an important role in glycolysis. As such, GC B cells' formation and immune responses were disturbed in LCMV-infected mice. These findings will provide new insights into the immunological pathogenesis of primary immunodeficiency disorder caused by DOCK8 mutation.